CON
Concentra Group Holdings Parent, Inc.
Medical - Equipment & Services
Market Cap$3.10B
5Y Perf.+3.6%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
CON vs SEM
Revenue, margins, valuation, and 5-year total return — side by side.
SEM
Select Medical Holdings Corporation
Medical - Care Facilities
Market Cap$2.04B
5Y Perf.-23.4%
CON vs SEM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | CON | SEM |
|---|---|---|
| Industry | Medical - Equipment & Services | Medical - Care Facilities |
| Market Cap | $3.10B | $2.04B |
| Revenue (TTM) | $2.23B | $5.52B |
| Net Income (TTM) | $178M | $134M |
| Gross Margin | 28.7% | 10.6% |
| Operating Margin | 89.9% | 5.8% |
| Forward P/E | 16.3x | 13.4x |
| Total Debt | $2.10B | $3.70B |
| Cash & Equiv. | $80M | $27M |
CON vs SEM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
CON
SEM
| Stock | Jul 24 | May 26 | Return |
|---|---|---|---|
| Concentra Group Hol… (CON) | 100 | 103.6 | +3.6% |
| Select Medical Hold… (SEM) | 100 | 76.6 | -23.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CON vs SEM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: CON leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Select Medical Holdings Corporation is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
CON
Concentra Group Holdings Parent, Inc.
The Growth Play
CON carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 13.9%, EPS growth 0.0%, 3Y rev CAGR 7.9%
- 13.9% revenue growth vs SEM's 5.1%
- 8.0% margin vs SEM's 2.4%
Best for: growth exposure
SEM
Select Medical Holdings Corporation
The Income Pick
SEM is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 0.66, yield 1.6%
- 158.1% 10Y total return vs CON's 9.1%
- Lower volatility, beta 0.66, current ratio 1.04x
Best for: income & stability and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | CON | 13.9% revenue growth vs SEM's 5.1% |
| Value | SEM | Lower P/E (13.4x vs 16.3x) |
| Quality / Margins | CON | 8.0% margin vs SEM's 2.4% |
| Stability / Safety | SEM | Beta 0.66 vs CON's 0.70, lower leverage |
| Dividends | SEM | 1.6% yield, vs CON's 1.0% |
| Momentum (1Y) | CON | +15.6% vs SEM's +13.4% |
| Efficiency (ROA) | CON | 6.1% ROA vs SEM's 2.3%, ROIC 69.4% vs 4.8% |
CON vs SEM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2025
CON vs SEM — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLCONLAGGINGSEM
SEMSelect Medical Holdin…
2leads
CONConcentra Group Holdi…
3leads
6 Total Categories
CATEGORYLEADERvs SEMMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
CON6/6
Valuation MetricsMultiples, price ratios, and targets
SEM5/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
CON7/8
Total Returns1Y, 3Y, 5Y total returns with dividends
CON5/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
SEM1/1
Income & Cash Flow (Last 12 Months)
CON leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SEM is the larger business by revenue, generating $5.5B annually — 2.5x CON's $2.2B. CON is the more profitable business, keeping 8.0% of every revenue dollar as net income compared to SEM's 2.4%. On growth, CON holds the edge at +13.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | CONConcentra Group H… | SEMSelect Medical Ho… |
|---|---|---|
| RevenueTrailing 12 months | $2.2B | $5.5B |
| EBITDAEarnings before interest/tax | $2.1B | $465M |
| Net IncomeAfter-tax profit | $178M | $134M |
| Free Cash FlowCash after capex | $293M | $117M |
| Gross MarginGross profit ÷ Revenue | +28.7% | +10.6% |
| Operating MarginEBIT ÷ Revenue | +89.9% | +5.8% |
| Net MarginNet income ÷ Revenue | +8.0% | +2.4% |
| FCF MarginFCF ÷ Revenue | +13.1% | +2.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +13.7% | +5.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +25.8% | -18.2% |
CON leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
SEM leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 13.9x trailing earnings, SEM trades at a 25% valuation discount to CON's 18.6x P/E. On an enterprise value basis, CON's 2.4x EV/EBITDA is more attractive than SEM's 12.0x.
| Metric | CONConcentra Group H… | SEMSelect Medical Ho… |
|---|---|---|
| Market CapShares × price | $3.1B | $2.0B |
| Enterprise ValueMkt cap + debt − cash | $5.1B | $5.7B |
| Trailing P/EPrice ÷ TTM EPS | 18.58x | 13.91x |
| Forward P/EPrice ÷ next-FY EPS est. | 16.29x | 13.36x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 2.37x | 12.03x |
| Price / SalesMarket cap ÷ Revenue | 1.44x | 0.37x |
| Price / BookPrice ÷ Book value/share | 7.37x | 1.00x |
| Price / FCFMarket cap ÷ FCF | 15.76x | 5.32x |
SEM leads this category, winning 5 of 6 comparable metrics.
Profitability & Efficiency
CON leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
CON delivers a 43.7% return on equity — every $100 of shareholder capital generates $44 in annual profit, vs $7 for SEM. SEM carries lower financial leverage with a 1.82x debt-to-equity ratio, signaling a more conservative balance sheet compared to CON's 5.00x.
| Metric | CONConcentra Group H… | SEMSelect Medical Ho… |
|---|---|---|
| ROE (TTM)Return on equity | +43.7% | +6.6% |
| ROA (TTM)Return on assets | +6.1% | +2.3% |
| ROICReturn on invested capital | +69.4% | +4.8% |
| ROCEReturn on capital employed | +84.9% | +7.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 |
| Debt / EquityFinancial leverage | 5.00x | 1.82x |
| Net DebtTotal debt minus cash | $2.0B | $3.7B |
| Cash & Equiv.Liquid assets | $80M | $27M |
| Total DebtShort + long-term debt | $2.1B | $3.7B |
| Interest CoverageEBIT ÷ Interest expense | 4.59x | 4.41x |
CON leads this category, winning 7 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
CON leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CON five years ago would be worth $10,914 today (with dividends reinvested), compared to $8,929 for SEM. Over the past 12 months, CON leads with a +15.6% total return vs SEM's +13.4%. The 3-year compound annual growth rate (CAGR) favors CON at 3.0% vs SEM's 2.3% — a key indicator of consistent wealth creation.
| Metric | CONConcentra Group H… | SEMSelect Medical Ho… |
|---|---|---|
| YTD ReturnYear-to-date | +24.8% | +11.2% |
| 1-Year ReturnPast 12 months | +15.6% | +13.4% |
| 3-Year ReturnCumulative with dividends | +9.1% | +7.2% |
| 5-Year ReturnCumulative with dividends | +9.1% | -10.7% |
| 10-Year ReturnCumulative with dividends | +9.1% | +158.1% |
| CAGR (3Y)Annualised 3-year return | +3.0% | +2.3% |
CON leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
Evenly matched — CON and SEM each lead in 1 of 2 comparable metrics.
Risk & Volatility
SEM is the less volatile stock with a 0.66 beta — it tends to amplify market swings less than CON's 0.70 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | CONConcentra Group H… | SEMSelect Medical Ho… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.70x | 0.66x |
| 52-Week HighHighest price in past year | $25.00 | $16.99 |
| 52-Week LowLowest price in past year | $18.55 | $11.65 |
| % of 52W HighCurrent price vs 52-week peak | +96.6% | +96.6% |
| RSI (14)Momentum oscillator 0–100 | 65.5 | 62.2 |
| Avg Volume (50D)Average daily shares traded | 695K | 2.1M |
Evenly matched — CON and SEM each lead in 1 of 2 comparable metrics.
Analyst Outlook
SEM leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates CON as "Buy" and SEM as "Hold". Consensus price targets imply 30.4% upside for CON (target: $32) vs 15.8% for SEM (target: $19). For income investors, SEM offers the higher dividend yield at 1.55% vs CON's 1.04%.
| Metric | CONConcentra Group H… | SEMSelect Medical Ho… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $31.50 | $19.00 |
| # AnalystsCovering analysts | 4 | 13 |
| Dividend YieldAnnual dividend ÷ price | +1.0% | +1.6% |
| Dividend StreakConsecutive years of raises | 0 | 0 |
| Dividend / ShareAnnual DPS | $0.25 | $0.25 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.7% | +4.9% |
SEM leads this category, winning 1 of 1 comparable metric.
Key Takeaway
CON leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SEM leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
Best OverallConcentra Group Holdings Pa… (CON)Leads 3 of 6 categories
Loading custom metrics...
CON vs SEM: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CON or SEM a better buy right now?
For growth investors, Concentra Group Holdings Parent, Inc.
(CON) is the stronger pick with 13. 9% revenue growth year-over-year, versus 5. 1% for Select Medical Holdings Corporation (SEM). Select Medical Holdings Corporation (SEM) offers the better valuation at 13. 9x trailing P/E (13. 4x forward), making it the more compelling value choice. Analysts rate Concentra Group Holdings Parent, Inc. (CON) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CON or SEM?
On trailing P/E, Select Medical Holdings Corporation (SEM) is the cheapest at 13.
9x versus Concentra Group Holdings Parent, Inc. at 18. 6x. On forward P/E, Select Medical Holdings Corporation is actually cheaper at 13. 4x.
03Which is the better long-term investment — CON or SEM?
Over the past 5 years, Concentra Group Holdings Parent, Inc.
(CON) delivered a total return of +9. 1%, compared to -10. 7% for Select Medical Holdings Corporation (SEM). Over 10 years, the gap is even starker: SEM returned +158. 1% versus CON's +9. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CON or SEM?
By beta (market sensitivity over 5 years), Select Medical Holdings Corporation (SEM) is the lower-risk stock at 0.
66β versus Concentra Group Holdings Parent, Inc. 's 0. 70β — meaning CON is approximately 6% more volatile than SEM relative to the S&P 500. On balance sheet safety, Select Medical Holdings Corporation (SEM) carries a lower debt/equity ratio of 182% versus 5% for Concentra Group Holdings Parent, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CON or SEM?
By revenue growth (latest reported year), Concentra Group Holdings Parent, Inc.
(CON) is pulling ahead at 13. 9% versus 5. 1% for Select Medical Holdings Corporation (SEM). On earnings-per-share growth, the picture is similar: Concentra Group Holdings Parent, Inc. grew EPS 0. 0% year-over-year, compared to -28. 9% for Select Medical Holdings Corporation. Over a 3-year CAGR, CON leads at 7. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CON or SEM?
Concentra Group Holdings Parent, Inc.
(CON) is the more profitable company, earning 8. 0% net margin versus 2. 7% for Select Medical Holdings Corporation — meaning it keeps 8. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CON leads at 96. 5% versus 6. 1% for SEM. At the gross margin level — before operating expenses — CON leads at 28. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CON or SEM more undervalued right now?
On forward earnings alone, Select Medical Holdings Corporation (SEM) trades at 13.
4x forward P/E versus 16. 3x for Concentra Group Holdings Parent, Inc. — 2. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CON: 30. 4% to $31. 50.
08Which pays a better dividend — CON or SEM?
All stocks in this comparison pay dividends.
Select Medical Holdings Corporation (SEM) offers the highest yield at 1. 6%, versus 1. 0% for Concentra Group Holdings Parent, Inc. (CON).
09Is CON or SEM better for a retirement portfolio?
For long-horizon retirement investors, Select Medical Holdings Corporation (SEM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
66), 1. 6% yield, +158. 1% 10Y return). Both have compounded well over 10 years (SEM: +158. 1%, CON: +9. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CON and SEM?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CON is a small-cap quality compounder stock; SEM is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(CON: 13.7% · SEM: 5.0%)Net Margin>
%
(CON: 8.0% · SEM: 2.4%)P/E Ratio<
x
(CON: 18.6x · SEM: 13.9x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.